이 웹사이트는 국립암센터국제암대학원대학교 공식 웹사이트 입니다.

전체메뉴 바로가기 본문바로가기

교육

교수진 소개

So-Youn JUNG, M.D., Ph.D

Name
So-Youn JUNG, M.D., Ph.D
Faculty Appointment
(title, department)
Associate Professor, Department of Cancer Biomedical Science, NCC-GCSP
Area of Expertise
Breast Cancer, Surgery
E-mail
goje1@ncc.re.kr
Work Experience
2002 – 2003 Internship, Seoul National University Hospital, Seoul, Korea
2003 – 2007 Residency, Department of Surgery,
Seoul National University Hospital, Seoul, Korea
2007 Fellowship, Department of Surgery, Seoul National University Hospital, Korea
2008 Fellowship, Center for Breast Cancer, National Cancer Center, Korea
2009.3 – present; Staff physician, Center for Breast Cancer Research Institute & Hospital, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea
Educational Background
1996 – 2002; Seoul National University College of Medicine, Seoul, Korea Degree: M.D.
2005 – 2007; Department of Surgery, Graduate School, Seoul National University College of Medicine, Seoul, Korea Degree: M.M.S
2007 –2015; Department of Surgery, Graduate School, Seoul National University College of Medicine, Seoul, Korea Degree. Ph.D
Research Interests
Dr Jung is a breast surgeon and researcher of Research Institute at National Cancer Center, Korea. She actively involved in breast cancer research for epidemiology, prognostic markers and survivorship.
International Collaboration
2007-Member, Korea Breast Cancer Society
Achievements
2019 SCI The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial: ANNALS OF SURGICAL ONCOLOGY. 26(8):2409~2416 (3.681)

2019 SCI Different Patterns of Conditional Survival of Breast Cancer Patients by Age and Histologic types: Evidence from the Korean Nationwide Registry: CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION. 28(7):1169~1176 (5.057)

2019 SCI Survival benefit of radiotherapy after surgery in de novo stage IV breast cancer: a population-based propensity-score matched analysis: SCIENTIFIC REPORTS. 9(1):8527~8527 (4.011)

2019 SCI Rapid histologic diagnosis using quick fluorescence staining and tissue confocal microscopy: Microscopy Research and Technique. 82(6):892~897 (1.327)

2019 기타 Radiaion-induced sarcoma after breast cancer treatment: Two cases with different prognosis: 대한유방검진학회지. 16:25~31 (0)

2019 SCI-E Prognostic Value of Post-Diagnosis Health-Related Quality of Life for Overall Survival in Breast Cancer: Findings from a 10-Year Prospective Cohort in Korea: CANCER RESEARCH AND TREATMENT. Online:Published (3.363)

2019 SCI-E Interaction Effect Between Breast Density and Reproductive Factors on Breast Cancer Risk in Korean Population: EUROPEAN JOURNAL OF CANCER PREVENTION. 24(1):26~32 (2.33)

2019 SCI Retrospectively validating the results of the ACOSOG Z0011trial in alarge Asian Z0011-eligible cohort: BREAST CANCER RESEARCH AND TREATMENT. Online:Published (3.471)

2019 SCI-E Prediagnosis obesity and secondary primary cancer risk in female cancer survivors: A national cohort study: CANCER MEDICINE. 8(2):824~838 (3.357)

2018 SCI-E Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: combined Statistical Modeling Using Clinicopathological Factors and FDG PET/CT Texture Parameters: clinical nuclear medicine. 44(1):21~29 (6.309)

2018 SCI-E Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers: CANCER RESEARCH AND TREATMENT. 51(1):280~288 (3.23)

2018 SCI-E Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice: Asian Journal of Surgery. 42(1):314~319 (1.895)

2018 SCI-E Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database: CANCER MEDICINE. 7(12):6084~6092 (3.202)

2018 SCI-E Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold.: Clinical breast cancer. 18(6):459~467 (2.703)

2018 SCI Prognostic impact of skeletal muscle volume derived from crosssectional computed tomography images in breast cancer: BREAST CANCER RESEARCH AND TREATMENT. 172(2):425~436 (3.605)

2018 SCI Differences in attitudes toward genetic testing among the public,patients, and health-care professionals in Korea: European journal of human genetics. 26(10):1432~1440 (3.636)

2018 SCI Factors associated with physical activity of breast cancer patients participating in exercise intervention: SUPPORTIVE CARE IN CANCER. Online:Published (2.676) 2018 SCI-E Incidence of Diabetes After Cancer Development : A Korean National Cohort Study: JAMA oncology. 4(8):1099~1105 (20.871)

2018 SCI Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay: Breast cancer research and treatment. 170(1):69~76 (3.605)

2018 SCI-E Dietary pattern and health-related quality of life among breast cancer survivors: BMC women's health. 18(1):65~65 (1.806)

2017 SCI-E Selective Radiation Therapy for Ductal Carcinoma In Situ Following Breast-Conserving Surgery According to Age and Margin Width: Korean Radiation Oncology Group 11-04 and 16-02 Studies: Journal of Breast Cancer. 20(4):327~332 (2.204)

2017 SCI-E Dietary factors and female breast cancer risk: a prospective cohort study: Nutrients. 9:1331~1331 (3.55)

2017 SCI-E CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer: PLOS ONE. 12(8):e0182107~e0182107 (2.806)

2017 SCI The association between physical activity and health-related quality of life among breast cancer survivors: Health Qual Life Outcomes. 15(1):132~132 (2.143)

2017 SCI-E Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer: Oncotarget. 8(20):32722~32730 (5.168)

2017 SCI Recurrence outcomes after omission of postoperative radiotherapy following breast-conserving surgery for ductal carcinoma in situ of the breast: a multicenter, retrospective study in Korea (KROG 16-02): Breast cancer research and treatment. 162(1):77~83 (3.626)

2016 SCI-E The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients: PLOS ONE. 11(10):e0163370~e0163370 (3.057)

2016 SCI-E Identification of Prognostic Risk Factors for Transient and Persistent Lymphedema after Multimodal Treatment for Breast Cancer: Cancer Research and Treatment. 48(4):1330~1337 (4.245)

2016 SCI-E Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment: Cancer research and treatment. 48(4):1363~1372 (4.245)

2016 SCI Identifying the potential long-term survivors among breast cancer patients with distant metastasis: Annals of oncology. 27(5):828~833 (9.269)

2016 SCI A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer: Medicine. 95(19):e3320~e3320 (2.133)

2015 SCI-E Effect of Time Interval between Breast-conserving Surgery and Radiation Therapy on Outcomes of Node-positive Breast Cancer Patients Treated with Adjuvant Doxorubicin/Cyclophosphamide followed by Taxane: Cancer research and treatment. 48(2):483~490 (3.318)

2015 SCI-E Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer: Clinical Breast Cancer. 16(1):51~58 (2.107)

2015 SCI-E Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical Outcome: Cancer research and treatment. 48(1):133~141 (3.318)

2015 SCI-E Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?: PLoS ONE. 10(12):e0145463~e0145463 (3.234)

2015 SCI Assessment of Breast Cancer Patients’ Knowledge and Decisional Conflict Regarding Tamoxifen Use: Journal of Korean Medical Science. 30(11):1604~1611 (1.266)

2015 SCI The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women.: Annals of surgical oncology. 22(11):3481~3488 (3.93)

2015 SCI Health Behaviors of Cancer Survivors in Nationwide Cross-Sectional Survey in Korea: Higher Alcohol Drinking, Lower Smoking, and Physical Inactivity Pattern in Survivors with Higher Household Income.: Medicine. 94(31):e1214~e1214 (5.723)

2015 SCI-E Breast Cancer-Related Lymphedema after Neoadjuvant Chemotherapy: Cancer research and treatment. 47(3):416~423 (3.318)

2015 기타 Sentinel lymph node mapping using tri-modal human serum albumin conjugated with visible dye, near infrared fluorescent dye and radioisotope: Journal of Radiopharmaceuticals and Molecular Probes. 1:62~73 (0)

2015 SCI-E The reality in the follow-up of breast cancer survivors:The reality in the follow-up of breast cancer survivors: Annals of surgical treatment and research. 88:133~139 (0)

2015 SCI A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer: Cancer letters. 356(2 Pt B):880~890 (5.621)

2014 SCI High Volumetric Breast Density Predicts Risk for Breast Cancer in Postmenopausal, but not Premenopausal, Korean Women: Annals of surgical oncology. 21(13):4124~4132 (3.943)

2014 SCI Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients: Breast cancer research and treatment. 148(1):91~98 (4.198)

2014 SCI-E A review of breast cancer survivorship issues from survivors' perspectives: Journal of breast cancer. 17(3):189~199 (1.317)

2014 SCI Comparison of Sentinel Lymph Node Biopsy Guided by the Multimodal Method of Indocyanine Green Fluorescence, Radioisotope, and Blue Dye Versus the Radioisotope Method in Breast Cancer: A Randomized Controlled Trial: Annals of Surgical Oncology. 21(4):1254~1259 (3.943)

2014 기타 SAPHO Syndrome in a Patient with Breast Cancer Mimicking Bone Metastasis: A Case Report: Journal of the Korean Society of Magnetic Resonance in Medicine. 18(1):59~63 (0)

2014 SCI-E Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR): BMC cancer. 14:170~174 (3.319)

2013 SCI Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer: International Journal of Radiation Oncology Biology Physics. 87(5):1037~1042 (4.524)

2013 SCI Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients: Breast Cancer Research and Treatment. 142(3):559~567 (4.469)

2013 SCI A Model to Estimate the Risk of Breast Cancer-Related Lymphedema: Combinations of Treatment-Related Factors of the Number of Dissected Axillary Nodes, Adjuvant Chemotherapy, and Radiation Therapy: International Journal of Radiation Oncology, Biology, Physics. 86(3):498~503 (4.524)

2012 SCI-E Stage-to-stage Comparison of Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Pathological Lymph Node Positive Breast Cancer Patients: Japanese Journal of Clinical Oncology. 42(11):995~1001 (1.783)

2012 SCI Predicting Nonsentinel Lymph Node Metastasis Using Lymphoscintigraphy in Patients with Breast Cancer: The Journal of Nuclear Medicine. 53(11):1693~1700 (6.381)

2012 SCI Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancer: Annals of Oncology. 23(9):2283~2289 (6.425)

2012 SCI Metaplastic breast cancer: clinicopathological features and its prognosis: Journal of clinical pathology. 65(5):441~446 (2.306)

2012 SCI Web-Based Tailored Education Program for Disease-Free Cancer Survivors With Cancer-Related Fatigue: A Randomized Controlled Trial: Journal of Clinical Oncology. 30(12):1296~1303 (18.372)

2012 SCI lack of any association between functionally significant CYP2D6 polymorphisms and clinical outcomes in early breast cancer patients receiving adjuvant tamoxifen treatment: Breast cancer research and treatment. 131(2):455~461 (4.431)

2011 SCI A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2 positive early breast cancer: Investigational New Drugs. 30(5):1972~1977 (3.357)

2011 SCI Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and radiotherapy following neoadjuvant chemotherapy.: International Journal of Radiation Oncology*Biology*Physics. 81(5):e697~e705 (4.503)

2011 SCI Outcomes of Positron Emission Tomography-Staged Clinical N3 Breast Cancer Treated with Neoadjuvant Chemotherapy, Surgery, and Radiotherapy.: Int J Radiat Oncol Biol Phys. 81(5):e689~e695 (4.503)

2011 SCI-E Protein and lipid MALDI profiles classify breast cancers according to the intrinsic subtype.: BMC cancer. 11:465~465 (3.153)

2011 SCI Accumulation of p53 determined by immunohistochemistry as a prognostic marker in node negative breast cancer; analysis according to st gallen consensus and intrinsic subtypes.: Journal of Surgical Oncology. 103(3):207~211 (2.428)

2010 SCI-E The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study.: BMC cancer. 10(1):664~664 (2.736)

2010 SCI Hypomethylation of the interleukin-10 gene in breast cancer tissues: Breast. 19(6):484~488 (2.087)

2010 SCI Methylation patterns of genes coding for drug-metabolizing enzymes in tamoxifen-resistant breast cancer tissues: Journal of Molecular medicine. 88(11):1123~1131 (5.004)

2010 SCI Predictive factors of pathologic complete response and clinical tumor progression after preoperative chemotherapy in patients with stage II and III breast cancer.: Investigational new drugs. Online:Published (3.072)

2010 SCI-E Oncological Safety and Quality of Life Associated with Mastectomy and Immediate Breast Reconstruction with a Latissimus Dorsi Myocutaneous Flap.: The breast journal. 16(4):356~361 (1.61)

2010 SCI Phase II Parallel Group Study Showing Comparable Efficacy Between Premenopausal Metastatic Breast Cancer Patients Treated With Letrozole Plus Goserelin and Postmenopausal Patients Treated With Letrozole Alone As First-Line Hormone Therapy: Journal of Clinical Oncology. 28(16):2705~2711 (17.793)

2010 SCI Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer: Breast cancer research and treatment. 120(3):627~637 (4.696)

2010 SCI Risk Factors for Malignancy in Benign Papillomas of the Breast on Core Needle Biopsy.: World Journal of Surgery. 34(2):261~265 (2.696)

2010 SCI Prognostic impact of [18F] FDG-PET in operable breast cancer treated with neoadjuvant chemotherpy: Annals of Surgical Oncology. 17(1):247~253 (4.13)

2009 SCI-E Gastric choriocarcinoma admixed with an alpha-fetoprotein-producing adenocarcinoma and separated adenocarcinoma.: World J Gastroenterol.. 15(40):5106~5108 (2.081)

2009 SCI Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer: Annals of Surgical Oncology. 16(5):1112~1121 (3.898)